Semaglutide is a peptide known as a glucagon-like peptide 1 (GLP1)
GLP1 can prompt the body to produce more insulin in response to eating, which reduces blood glucose levels. Semaglutide is an injection to treat the chronic metabolic disease of obesity by interacting with the part of the brain that suppresses appetite and signals fullness. Research has shown that with a reduction in obesity there can be a reduced risk of cancer, diabetes and heart disease.
*Reconstitute lyophilized powder with bacteriostatic water* *NOT INCLUDED. MUST BE ORDERED SEPARATELY*
